Organovo Holdings, Inc. (NASDAQ:ONVO) was downgraded by research analysts at Raymond James Financial, Inc. from an “outperform” rating to a “market perform” rating in a research report issued to clients and investors on Friday. They presently have a $5.00 price objective on the stock. Raymond James Financial, Inc.’s price objective would suggest a potential upside of 224.68% from the company’s current price.
Other analysts have also issued research reports about the stock. BidaskClub lowered shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a report on Tuesday, July 25th. Jefferies Group LLC reissued a “buy” rating and issued a $4.00 price target on shares of Organovo Holdings in a report on Thursday, July 27th. ValuEngine lowered shares of Organovo Holdings from a “sell” rating to a “strong sell” rating in a report on Friday, September 1st. Finally, Zacks Investment Research raised shares of Organovo Holdings from a “hold” rating to a “buy” rating and set a $2.25 price target for the company in a report on Wednesday, October 11th. Two research analysts have rated the stock with a sell rating, two have given a hold rating and four have issued a buy rating to the company. Organovo Holdings has an average rating of “Hold” and an average target price of $6.00.
Organovo Holdings (NASDAQ ONVO) opened at $1.54 on Friday. Organovo Holdings has a one year low of $1.32 and a one year high of $4.08.
Organovo Holdings (NASDAQ:ONVO) last posted its earnings results on Thursday, November 9th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.01. Organovo Holdings had a negative net margin of 923.89% and a negative return on equity of 62.67%. The company had revenue of $1.36 million during the quarter, compared to analysts’ expectations of $1.38 million. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. equities analysts forecast that Organovo Holdings will post -0.37 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: This piece was reported by Markets Daily and is the property of of Markets Daily. If you are accessing this piece on another site, it was copied illegally and republished in violation of United States and international copyright and trademark law. The original version of this piece can be accessed at https://www.themarketsdaily.com/2017/11/12/raymond-james-financial-inc-downgrades-organovo-holdings-inc-onvo-to-market-perform.html.
Institutional investors have recently modified their holdings of the stock. Bank of America Corp DE increased its holdings in shares of Organovo Holdings by 34.0% in the first quarter. Bank of America Corp DE now owns 35,311 shares of the company’s stock valued at $113,000 after purchasing an additional 8,967 shares in the last quarter. Voya Investment Management LLC grew its holdings in Organovo Holdings by 18.8% during the 2nd quarter. Voya Investment Management LLC now owns 52,032 shares of the company’s stock worth $137,000 after acquiring an additional 8,225 shares during the period. American International Group Inc. grew its holdings in Organovo Holdings by 7.9% during the 1st quarter. American International Group Inc. now owns 53,431 shares of the company’s stock worth $170,000 after acquiring an additional 3,920 shares during the period. Metropolitan Life Insurance Co. NY grew its holdings in Organovo Holdings by 15.0% during the 1st quarter. Metropolitan Life Insurance Co. NY now owns 68,487 shares of the company’s stock worth $218,000 after acquiring an additional 8,958 shares during the period. Finally, Tudor Investment Corp ET AL grew its holdings in Organovo Holdings by 141.7% during the 1st quarter. Tudor Investment Corp ET AL now owns 75,000 shares of the company’s stock worth $238,000 after acquiring an additional 43,965 shares during the period. 24.02% of the stock is owned by institutional investors and hedge funds.
About Organovo Holdings
Receive News & Ratings for Organovo Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organovo Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.